Unlocking potential:
How AI is shaping the drug development pipeline

Join Charlotte Guzzo and experts Parker Moss, Margo Georgiadis, and Guillermo de Angel in a one-hour webinar exploring AI's impact on drug development. This discussion will cover AI's significant contributions to the field, the relationship between data growth and algorithmic innovation, and AI utilisation in large pharma versus biotech. The session aims to provide practical insights into how various organisations leverage AI for drug discovery and development efficiencies, and what that means for the future of healthcare.